Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study

被引:29
|
作者
Skvrce, Nikica Miroevic [1 ]
Sarinic, Viola Macolic [1 ]
Mucalo, Iva [2 ]
Krnic, Darko [1 ]
Bozina, Nada [3 ,4 ]
Tomic, Sinisa
机构
[1] Agcy Med Prod & Med Devices, Pharmacovigilance Dept, Zagreb, Croatia
[2] Univ Zagreb, Ctr Appl Chem, Fac Pharm & Biochem, Zagreb 41000, Croatia
[3] Univ Sch Med, Dept Lab Diagnost, Zagreb, Croatia
[4] Univ Hosp Ctr, Zagreb, Croatia
关键词
EMERGENCY-DEPARTMENT VISITS; HOSPITAL-ADMISSIONS; ELDERLY PATIENTS; CLINICAL-RELEVANCE; DETECTING SIGNALS; POTENTIAL RISKS; DATABASE; EVENTS; PREVENTION; PHARMACOVIGILANCE;
D O I
10.3325/cmj.2011.52.604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To analyze potential and actual drug-drug interactions reported to the Spontaneous Reporting Database of the Croatian Agency for Medicinal Products and Medical Devices (HALMED) and determine their incidence. Methods In this retrospective observational study performed from March 2005 to December 2008, we detected potential and actual drug-drug interactions using interaction programs and analyzed them. Results HALMED received 1209 reports involving at least two drugs. There were 468 (38.7%) reports on potential drug-drug interactions, 94 of which (7.8% of total reports) were actual drug-drug interactions. Among actual drug-drug interaction reports, the proportion of serious adverse drug reactions (53 out of 94) and the number of drugs (n = 4) was significantly higher (P < 0.001) than among the remaining reports (580 out of 1982; n = 2, respectively). Actual drug-drug interactions most frequently involved nervous system agents (34.0%), and interactions caused by antiplatelet, anticoagulant, and non-steroidal anti-inflammatory drugs were in most cases serious. In only 12 out of 94 reports, actual drug-drug interactions were recognized by the reporter. Conclusion The study confirmed that the Spontaneous Reporting Database was a valuable resource for detecting actual drug-drug interactions. Also, it identified drugs leading to serious adverse drug reactions and deaths, thus indicating the areas which should be in the focus of health care education.
引用
收藏
页码:604 / 614
页数:11
相关论文
共 50 条
  • [21] Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions
    Crescioli, Giada
    Brilli, Valentina
    Lanzi, Cecilia
    Burgalassi, Andrea
    Ieri, Alessandra
    Bonaiuti, Roberto
    Romano, Elias
    Innocenti, Rinaldo
    Mannaioni, Guido
    Vannacci, Alfredo
    Lombardi, Niccolo
    INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (03) : 697 - 710
  • [22] Spontaneously Reported Adverse Drug Reactions and Their Description in Hospital Discharge Reports: A Retrospective Study
    Aguilera, Cristina
    Agusti, Antonia
    Perez, Eulalia
    Gracia, Rosa M.
    Diogene, Eduard
    Danes, Immaculada
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (15)
  • [23] Identifying Adverse Drug Reactions Associated with Drug-Drug Interactions Data Mining of a Spontaneous Reporting Database in Italy
    Leone, Roberto
    Magro, Lara
    Moretti, Llgo
    Cutroneo, Paola
    Moschini, Martina
    Motola, Domenico
    Tuccori, Marco
    Conforti, Anita
    DRUG SAFETY, 2010, 33 (08) : 667 - 675
  • [24] Adverse drug reactions in the ambulatory internal patients at the emergency department: Focus on causality assessment and drug-drug interactions
    Verbic, Matej Dobravc
    Brvar, Miran
    Kos, Mojca Kerec
    ACTA PHARMACEUTICA, 2023, 73 (02) : 195 - 210
  • [25] Adverse drug reactions caused by drug-drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items
    Kovacevic, Milena
    Kovacevic, Sandra Vezmar
    Radovanovic, Slavica
    Stevanovic, Predrag
    Miljkovc, Branislava
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (11) : 1873 - 1883
  • [26] Adverse reactions of immune checkpoint inhibitors combined with Proton pump inhibitors: a pharmacovigilance analysis of drug-drug interactions
    Ren, Xiayang
    Li, Lu
    Chen, Yiran
    Cui, Xiangli
    Wan, Rui
    Wang, Yanfeng
    BMC CANCER, 2024, 24 (01)
  • [27] A Retrospective Observational Study of Adverse Drug Reactions (ADR) Reported to ADR Monitoring Centre from 2010 to 2020
    Srinivasan, Akila
    Selvarajan, Sandhiya
    Shivabasappa, Santhosh
    Arunmozhy, S.
    CURRENT DRUG SAFETY, 2024,
  • [28] Polypharmacy, Aging and Potential Drug-Drug Interactions in Outpatients in Taiwan A Retrospective Computerized Screening Study
    Lin, Chen-Fang
    Wang, Chun-Yu
    Bai, Chyi-Huey
    DRUGS & AGING, 2011, 28 (03) : 219 - 225
  • [29] Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study.
    Boukhlal, Sara
    Chouchana, Laurent
    Saadi, Malika
    Casadevall, Marion
    Cohen, Pascal
    Dunogue, Bertrand
    Murarasu, Anne
    Regent, Alexis
    Mouthon, Luc
    Chaigne, Benjamin
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 67
  • [30] Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug-drug interactions: a PharmacoVigilance study in France
    Danton, Anne Charlotte
    Montastruc, Francois
    Sommet, Agnes
    Durrieu, Genevieve
    Bagheri, Haleh
    Bondon-Guitton, Emmanuelle
    Lapeyre-Mestre, Maryse
    Montastruc, Jean-Louis
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (04) : 885 - 888